We moved into a new and larger office space!
Given the growth of our team over the past year, we were excited to open our new office in December.
The new space offers more individual work stations, collaborative areas for project teams to work together, and we didn’t forget our always competitive foosball table.
Latest Insights
Jump to a slide with the slide dots.
John Valdes
Designing a Seamless Transition Between Patient Support Vendors: A Strategic Framework for Biopharma
How biopharma can transition patient support vendors while minimizing disruption and improving the patient and provider experience.
Read more
Chaitanya Sharma
OBBBA Medicaid Eligibility Shifts: Implications for Pharma Market Access Strategy
PURE Engagement: OBBBA Medicaid shifts may raise coverage churn, provider risk, and affordability pressures—forcing pharma to rethink market access.
Read more
Ashwini Chidirala
Overcoming the Challenges in Bringing Cell & Gene Therapies to Market
Overcome CGT capacity challenges with strategies for forecasting, staffing, and treatment center partnerships.
Read more
Ashwini Chidirala
Overcoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 2
How CGT manufacturers can reduce treatment center burden through better workflows, training, logistics, and system integration.
Read more
Ashwini Chidirala
Overcoming the Challenges in Bringing Cell & Gene Therapies to Market – Part 3
How CGT manufacturers can reduce financial risk and reimbursement burden for treatment centers adopting commercial therapies.
Read more